Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoSAMBA: Sequence of Anthracycline and Taxane in Locally Advanced Breast Cancer
NCT01270373Phase 2Unknown
- Sponsor
- Instituto Nacional de Câncer José Alencar Gomes da Silva
- Start
- Aug 2010
- Primary completion
- Apr 2020
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of docetaxel, pegylated liposomal doxorubicin, cyclophosphamide and fluorouracil in breast cancer (2 arms), sponsored by Instituto Nacional de Câncer José Alencar Gomes da Silva. Primary endpoint: Pathological Complete Response at 6 months. Status: unknown.
02
Drugs
docetaxelpegylated liposomal doxorubicincyclophosphamidefluorouracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01270373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270373.